
PEDIATRIX MEDICAL GROUP INC
MDNYSETrading Snapshot
- Day Range
- $26.00 โ $26.54
- 52-Week Range
- $14.05 โ $27.94
- Volume
- $2.65B
- Avg Volume
- $2.93B
- Shares Outstanding
- 82.1M
- Next Earnings
- Sep 11, 2026
Fundamentals Snapshot
- Annual Revenue
- $1.91B
- Last Q Revenue
- $488M
- P/E Ratio
- 12.1
- P/S Ratio
- 1.1x
- EPS (TTM)
- $2.08
- Dividend Yield
- โ
Why Investors Own MD
- โHigh-growth profile โ revenue up +37.4% YoY with expanding US Equity exposure.
- โHealthy economics โ 61% gross margin and 7% free-cash-flow margin.
- โNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About PEDIATRIX MEDICAL GROUP INC
Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix provides comprehensive maternal-fetal medicine services in both clinical and inpatient settings, involving specialists such as maternal-fetal medicine physicians, obstetricians, and genetic counselors. Furthermore, the group delivers pediatric cardiology services, addressing both congenital and acquired heart conditions in patients ranging from the fetal stage through adulthood, under the care of dedicated pediatric cardiologists. Beyond these core areas, Pediatrix extends its expertise to various other pediatric subspecialties, including those requiring intensivists, surgeons, and ophthalmologists, and supplies vital support to hospital departments like emergency rooms and labor and delivery units. Established in 1979 in Sunrise, Florida, and formerly known as MEDNAX, Inc. until its renaming in July 2022, the company managed a network of approximately 2,700 physicians as of February 2022.
Otter Score Breakdown
โAnalyst Ratings
โLatest News & Updates
UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $28
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $25 to $28.

Pediatrix Medical Group, Inc. (MD) Q2 2026 Earnings Call Transcript
Pediatrix Medical Group, Inc. (MD) Q2 2026 Earnings Call August 4, 2026 9:00 AM EDTCompany ParticipantsMark Ordan - CEO & Executive ChairmanKasandra...
Pediatrix Medical Group (NYSE:MD) Q2 EPS Beats Expectations, but Revenue Falls Just Short
Pediatrix Q2 adjusted EPS beats at $0.63, revenue roughly in line, but shares dip ~4.6% on soft volumes.

Full Transcript: Pediatrix Medical Group Q2 2026 Earnings Call
Pediatrix Medical Group (NYSE:MD) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday's pre-market session. The company's market cap stands at $4.3 million. Adagio Medical Holdings (NASDAQ:ADGM) stock
Pediatrix Medical Group Q2 Adj. EPS $0.63 Beats $0.59 Estimate, Sales $487.783M Beat $478.449M Estimate
Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.59 by 6.78 percent. This is a 18.87 percent increase over earnings of $0.53 per share from